Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

active_not_recruiting133%
completed267%

Recent Activity

1 active trials
Showing 3 of 3
completednot_applicable

Ultrasound-Guided Stellate Ganglion Block Plus Propofol for Perimenopausal Insomnia With Anxiety

NCT07384468
active_not_recruitingnot_applicable

Stellate Ganglion Block for PTSD

NCT05169190
completednot_applicable

Stellate Ganglion Block in Herpes Zoster

NCT04188327

Clinical Trials (3)

Showing 3 of 3 trials
NCT07384468Not Applicable

Ultrasound-Guided Stellate Ganglion Block Plus Propofol for Perimenopausal Insomnia With Anxiety

Completed
NCT05169190Not Applicable

Stellate Ganglion Block for PTSD

Active Not Recruiting
NCT04188327Not Applicable

Stellate Ganglion Block in Herpes Zoster

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3